StockWatch
·

VIJAY SOLVEX LTD.

BSE: 531069

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
622.65
-9.2%+35.2%
Expenditure
615.08
-9.0%+34.0%
Net Profit
5.58
-15.0%+448.6%
OPM %
1.40%
-0.58pp+0.83pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00191.93383.86575.79767.72Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Vijay Solvex Q1 FY27: consolidated PAT up 4.3x YoY to ₹5.58 Cr on lower input costs

edible oils · ceramics · margin expansion

ResultsQ1 FY2714 Aug 20263 minFMCG
Latest
Board Meeting14 Aug, 1:53 pm

Vijay Solvex Q1 FY27: consolidated PAT up 4.3x YoY to ₹5.58 Cr on lower input costs

Vijay Solvex, an Alwar-based edible oil and ceramics company, posted consolidated Q1 FY27 (quarter ended June 30, 2026) revenue of ₹622.50 Cr, up 35.2% YoY (₹460.42 Cr) but down 9.2% QoQ (₹685.44 Cr) — the sequential dip reflects normal seasonality in edible oils, where the Jan-Mar quarter typically captures peak crushing volumes ahead of the new mustard crop. Consolidated PAT was ₹5.58 Cr versus ₹1.06 Cr a year ago (+429%) and ₹6.78 Cr in Q4 FY26 (-18% QoQ). Standalone PAT (₹5.58 Cr) was almost identical to consolidated — associates contributed just ₹0.08 Cr this quarter against ₹0.22 Cr in Q4 FY26 and ₹0.04 Cr a year ago, so the two bases tell the same story. The YoY profit jump was margin-driven rather than a one-off: cost of materials consumed fell to 63.4% of revenue from 78.8% a year ago, lifting net profit margin to 0.90% from 0.23% and operating (EBIT) margin to 1.31% from 0.47%; finance cost also eased to ₹0.57 Cr from ₹0.69 Cr. Sequentially, both margins slipped (NPM 0.99%→0.90%, EBIT margin 1.91%→1.31%) alongside the seasonal revenue decline. Edible Oils (98.9% of consolidated revenue) grew 35.1% YoY with segment profit more than tripling to ₹8.01 Cr from ₹2.10 Cr; the smaller Ceramics segment grew revenue 45.8% YoY to ₹6.89 Cr with profit rising to ₹0.13 Cr from ₹0.04 Cr. There is no analyst coverage or consensus estimate publicly available for this micro-cap — a web search for Q1 FY27 previews returned nothing specific to Vijay Solvex — and the company carries no formal guidance on record, so the print cannot be benchmarked against street or management expectations. No management press release accompanied the filing beyond the standard BSE board-outcome letter; results were reviewed (not audited) by Aggarwal Datta & Co. Other board actions this quarter — fixing the September 28, 2026 AGM, book closure/e-voting cut-off dates, and re-appointment of Pallavi Sharma as independent director — are governance housekeeping unconnected to the operating numbers; small on-market share purchases by promoter entity Deepak Vegpro in June 2026 predate the results.

14 Aug 2026, 01:53 pm

Corporate Events

Board MeetingVIJSOLX
2026
28Sep

Board Meeting

The ensuing 38th Annual General Meeting of the Company is sc…

BSE Filing
Board MeetingVIJSOLX
2026
14Aug

Board Meeting

To consider and approve the Un-audited Standalone and Consol…

BSE Filing
Board MeetingVIJSOLX
2026
20Jul

Board Meeting

The Board of Directors considered and approved the re-appoin…

BSE Filing
Board MeetingVIJSOLX
2026
30May

Board Meeting

To consider and approve the Audited Standalone and Consolida…

BSE Filing
Board MeetingVIJSOLX
2024
14Nov

Board Meeting

Consider and approve the Un-Audited Standalone and Consolida…

BSE Filing
Board MeetingVIJSOLX
2023
14Nov

Board Meeting

Consider and approve the Un-audited Standalone and Consolida…

BSE Filing
Board MeetingVIJSOLX
2023
14Aug

Board Meeting

Consider and approve Un-audited Standalone and Consolidated …

BSE Filing